dihydroergotamine has been researched along with HIV Coinfection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Detriche, G; Di Primio, M; Durivage, A; El Batti, S; Goudot, G; Khider, L; Messas, E; Mirault, T; Mohamedi, N; Sapoval, M | 1 |
| Alves, M; Guidet, B; Janneau-Magrino, L; Legendre, N; Pateron, D; Yordanov, Y | 1 |
1 review(s) available for dihydroergotamine and HIV Coinfection
| Article | Year |
|---|---|
Ergotism with acute limb ischemia, provoked by HIV protease inhibitors interaction with ergotamine, rescued by multisite transluminal balloon angioplasty.
Topics: Acute Disease; Adult; Angioplasty, Balloon; Dihydroergotamine; Ergotism; Female; HIV Infections; HIV Protease Inhibitors; Humans; Ischemia; Lower Extremity; Risk Factors; Treatment Outcome; Vasoconstrictor Agents | 2021 |
1 other study(ies) available for dihydroergotamine and HIV Coinfection
| Article | Year |
|---|---|
Human immunodeficiency virus post-exposure prophylaxis: primum non nocere.
Topics: Adult; Antiviral Agents; Bipolar Disorder; Cytochrome P-450 CYP3A Inhibitors; Dihydroergotamine; Drug Synergism; Drug Therapy, Combination; Ergotism; Female; HIV Infections; Humans; Hypotension, Orthostatic; Lamivudine; Lopinavir; Post-Exposure Prophylaxis; Ritonavir; Vasoconstrictor Agents; Zidovudine | 2015 |